Cathay Biotech Inc. (688065.SS) SHH

46.02

+0.59(+1.30%)

Updated at December 05 02:18PM

Currency In CNY

Valuation

Market Cap22.59B
Enterprise Value19.1B
P/E Ratio54.94
PEG Ratio16.3
Price/Sales Ratio9.97
Price/Book Ratio1.86
Enterprise/Revenue7.59
Enterprise/EBITDA38.63

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.18
Operating Margin0.19

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue2.96B
Revenue/Share4.57
Gross Profit836.44M
EBITDA679.85M
Net Income488.96M
Diluted EPS0.84

Balance Sheet

Total Cash9.01B
Total Cash/Share12.53
Total Debt279.23M
Total Debt/Equity0.02
Current Ratio6.94
Book Value Per Share29.51

Price History

52-Week Change0.35
52-Week High56.16
52-Week Low36.81
Moving Average 50 Days49.7
Moving Average 200 Days49.66

Statistics

Average Volume3.92M
Shares Outstanding721.29M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.4
Trailing Annual Dividend Yield0.88
Payout Ratio0.04
Last Split Factor7:5
Last Split DateJuly 20, 2022